Jazz Pharmaceuticals
JAZZ
#1899
Rank
NZ$17.84 B
Marketcap
NZ$293.75
Share price
1.67%
Change (1 day)
40.32%
Change (1 year)

Jazz Pharmaceuticals (JAZZ) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$12.80 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's total liabilities are NZ$12.80 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jazz Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$14.04 B15.97%
2023-12-31NZ$12.10 B-0.81%
2022-12-31NZ$12.20 B0.04%
2021-12-31NZ$12.20 B206.07%
2020-12-31NZ$3.98 B10.57%
2019-12-31NZ$3.60 B-1.14%
2018-12-31NZ$3.64 B7.44%
2017-12-31NZ$3.39 B-19.56%
2016-12-31NZ$4.21 B66.55%
2015-12-31NZ$2.53 B0.88%
2014-12-31NZ$2.51 B118.93%
2013-12-31NZ$1.14 B11.65%
2012-12-31NZ$1.02 B1219.18%
2011-12-31NZ$77.88 M-42.87%
2010-12-31NZ$0.13 B-45.06%
2009-12-31NZ$0.24 B-31.55%
2008-12-31NZ$0.36 B82.02%
2007-12-31NZ$0.19 B-64.1%
2006-12-31NZ$0.55 B33.98%
2005-12-31NZ$0.41 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Endo International
ENDPQ
NZ$20.31 B 58.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
NZ$104.30 B 714.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$108.25 B 745.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
NZ$56.43 B 340.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel